IRIS PubliCatt

Trecarichi, Enrico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.478
NA - Nord America 2.652
AS - Asia 1.428
AF - Africa 16
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 8.606
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.629
DE - Germania 2.502
CN - Cina 1.023
SE - Svezia 535
UA - Ucraina 291
IT - Italia 280
GB - Regno Unito 225
FR - Francia 208
IE - Irlanda 133
SG - Singapore 129
FI - Finlandia 84
ID - Indonesia 79
TR - Turchia 79
IN - India 65
RU - Federazione Russa 64
PL - Polonia 61
BE - Belgio 23
NL - Olanda 15
CA - Canada 14
HK - Hong Kong 13
RO - Romania 11
IR - Iran 9
BR - Brasile 7
CH - Svizzera 7
IL - Israele 7
MX - Messico 7
AU - Australia 6
EU - Europa 6
JP - Giappone 6
CI - Costa d'Avorio 5
CO - Colombia 5
ES - Italia 5
VA - Santa Sede (Città del Vaticano) 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
ET - Etiopia 3
HR - Croazia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
BZ - Belize 2
CM - Camerun 2
DJ - Gibuti 2
KR - Corea 2
ME - Montenegro 2
MU - Mauritius 2
PK - Pakistan 2
VN - Vietnam 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
IQ - Iraq 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 8.606
Salva come PNG Salva come JPEG
Città #
Chandler 552
Hangzhou 440
Jacksonville 205
Nürnberg 202
San Mateo 153
Ashburn 145
Ann Arbor 144
Nanjing 136
Dublin 132
Dearborn 118
Beijing 107
Singapore 86
Wilmington 81
Jakarta 79
Izmir 73
New York 70
Woodbridge 63
Lawrence 56
Kraków 55
Marseille 55
Boston 52
Milan 52
Nanchang 52
Moscow 51
Cattolica 45
Houston 45
Redwood City 44
Munich 41
Bremen 37
Seattle 36
Kunming 31
Los Angeles 30
Chicago 28
Shenyang 27
Brussels 23
Tianjin 23
Mountain View 22
Hebei 21
Princeton 21
Norwalk 20
Helsinki 19
Changsha 18
Leawood 17
Redmond 17
Boardman 16
Lancaster 16
Guangzhou 15
University Park 15
Fairfield 14
Rome 14
Fremont 13
Jinan 13
Costa Mesa 12
Hong Kong 12
Zhengzhou 12
Augusta 11
Jiaxing 11
Shanghai 11
Auburn Hills 9
Hefei 8
Ningbo 8
Pune 8
San Jose 8
Renton 7
Andover 6
Buffalo 6
Cambridge 6
Edinburgh 6
Falls Church 6
Lanzhou 6
Monza 6
Timisoara 6
Verona 6
Abidjan 5
Ottawa 5
Stockholm 5
Amsterdam 4
Brooklyn 4
Budapest 4
Chongqing 4
Delhi 4
Mcallen 4
Mexico City 4
Old Bridge 4
Rende 4
Rotonda 4
Sofia 4
São Paulo 4
Taizhou 4
Albuquerque 3
Busto Arsizio 3
Changchun 3
Detroit 3
Filadelfia 3
Kocaeli 3
Madrid 3
Medellín 3
Nuremberg 3
Rimini 3
San Diego 3
Totale 4.111
Salva come PNG Salva come JPEG
Nome #
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 309
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 309
Factors associated with mortality in bacteremic patients with haematologic malignancies 297
Factors associated with mortality in bacteremic patients with hematologic malignancies. 297
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 275
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 234
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 233
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 212
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 173
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 170
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 161
Factors associated with mortality in bacteremic patients with hematologic malignancies. 161
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 159
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 158
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 148
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 147
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 146
Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome 144
Safety and effectiveness of transvenous lead extraction in octogenarians 143
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 139
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 136
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 135
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 131
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 131
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 129
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 126
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 122
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 117
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 114
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 111
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 107
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 104
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 101
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 101
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 98
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 94
Uncommon yeast infections in hematological patients: from diagnosis to treatment 93
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 92
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 90
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 90
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 90
Mortality in patients with early- or late-onset candidaemia 87
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 85
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study 85
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 84
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 84
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 83
Mortality in patients, with early-or late-onset candidaemia 82
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 82
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 80
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 80
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 79
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 77
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 77
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 75
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 74
Mortality in patients with early- or late-onset candidaemia 70
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 69
Epidemiological and clinical features of pyogenic spondylodiscitis. 68
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 68
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 67
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 67
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 63
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 62
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia 60
Mortality in patients with early- or late-onset candidaemia 54
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 53
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 52
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 50
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections 47
Isavuconazole-Animal Data and Clinical Data 46
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 46
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 44
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 43
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 41
When Viruses Meet Fungi: Tackling the Enemies in Hematology 37
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 27
Bloodstream infections caused by extended-spectrum-β-lactamase- producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy 18
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 7
Totale 8.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.176 0 0 77 68 159 192 155 71 112 111 113 118
2020/2021715 75 77 20 66 80 52 64 29 107 15 117 13
2021/2022856 83 83 47 48 52 39 12 140 38 63 116 135
2022/20231.567 191 223 115 246 89 196 86 126 176 29 69 21
2023/2024649 39 198 13 26 19 91 48 23 9 25 81 77
2024/2025173 50 35 88 0 0 0 0 0 0 0 0 0
Totale 8.700